“科创板八条”一周年，多位科创板公司掌门人发声！

Core Viewpoint - The "Eight Measures for Deepening the Reform of the Sci-Tech Innovation Board" have shown initial results in supporting technology innovation and enhancing the quality of capital markets for innovative companies since their release nearly a year ago [1][2][3][4][5] Group 1: Company Responses and Initiatives - Ailis has actively responded to the "Eight Measures" by increasing R&D investment and expanding international collaborations, particularly in the global rollout of its product, Furmetin [1] - Baillie Tianheng has initiated a private placement to raise funds for innovative drug R&D, benefiting from the supportive policies for unprofitable companies [2] - Crystal Integration has successfully registered a 2 billion yuan technology innovation bond to enhance financing efficiency and has implemented a second phase of its equity incentive plan to attract and retain talent [2][3] - Tianyue Advanced has launched the world's first 12-inch silicon carbide substrate, achieving profitability with a net profit of 179 million yuan in 2024 [3] - Chip Origin has progressed with its refinancing project under the "light asset, high R&D investment" standard, aiming to accelerate its strategic layout in Chiplet technology [4][5] Group 2: Suggestions for Further Reform - Ailis suggests introducing more long-term capital and enhancing international connectivity for quality sci-tech companies [1] - Baillie Tianheng calls for an optimized regulatory mechanism for unprofitable companies and a diversified refinancing toolset to support long-term R&D enterprises [2] - Tianyue Advanced recommends increasing the institutional inclusivity for core technology companies in capital operations like refinancing and mergers [3] - Chip Origin emphasizes the importance of mergers and acquisitions to enhance industry collaboration and strengthen competitive positioning [4][5]